Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 697

1.

Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.

Angelico M, Cillo U, Fagiuoli S, Gasbarrini A, Gavrila C, Marianelli T, Costa AN, Nardi A, Strazzabosco M, Burra P, Agnes S, Baccarani U, Calise F, Colledan M, Cuomo O, De Carlis L, Donataccio M, Ettorre GM, Gerunda GE, Gridelli B, Lupo L, Mazzaferro V, Pinna A, Risaliti A, Salizzoni M, Tisone G, Valente U, Rossi G, Rossi M, Zamboni F; Liver Match Investigators..

Dig Liver Dis. 2011 Feb;43(2):155-64. doi: 10.1016/j.dld.2010.11.002.

PMID:
21185796
2.

Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.

Angelico M, Nardi A, Marianelli T, Caccamo L, Romagnoli R, Tisone G, Pinna AD, Avolio AW, Fagiuoli S, Burra P, Strazzabosco M, Costa AN; Liver Match Investigators..

J Hepatol. 2013 Apr;58(4):715-23. doi: 10.1016/j.jhep.2012.11.025.

PMID:
23201239
3.

Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.

Maluf DG, Edwards EB, Stravitz RT, Kauffman HM.

Liver Transpl. 2009 Jun;15(6):592-9. doi: 10.1002/lt.21699.

4.

Liver transplantation in the United States.

Qiu J, Ozawa M, Terasaki PI.

Clin Transpl. 2005:17-28.

PMID:
17424722
5.

UNOS Liver Registry: ten year survivals.

Waki K.

Clin Transpl. 2006:29-39.

PMID:
18368704
6.

Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.

Smits JM, Vanhaecke J, Haverich A, de Vries E, Smith M, Rutgrink E, Ramsoebhag A, Hop A, Persijn G, Laufer G.

Clin Transpl. 2003:89-100.

PMID:
15387100
7.

Outcomes of liver transplantation from hepatitis B core antibody-positive donors in viral cirrhosis patients: the prevailing negative effect of recipient hepatitis C virus infection.

Tandoi F, Romagnoli R, Martini S, Mazza E, Nada E, Cocchis D, Lupo F, Salizzoni M.

Transplant Proc. 2012 Sep;44(7):1963-5. doi: 10.1016/j.transproceed.2012.05.064.

PMID:
22974883
8.

Liver transplantation in the United States: 1988 to 1990.

Belle SH, Beringer KC, Murphy JB, Plummer CC, Breen TJ, Edwards EB, Daily OP, Detre KM.

Clin Transpl. 1991:13-29.

PMID:
1820110
9.

Liver transplantation in the United States: a report from the UNOS Liver Transplant Registry.

Smith CM, Davies DB, McBride MA.

Clin Transpl. 1999:23-34.

PMID:
11038623
10.

Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.

Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.

Liver Transpl. 2009 May;15(5):496-503. doi: 10.1002/lt.21606.

11.

Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.

Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.

Liver Transpl. 2003 Jul;9(7):737-40.

12.

Cadaver kidney allocation in the north Italy transplant program on the eve of the new millennium.

Sirchia G, Poli F, Cardillo M, Scalamogna M, Rebulla P, Taioli E, Remuzzi G, Nocera A.

Clin Transpl. 1998:133-45.

PMID:
10503092
13.

The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality.

Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM.

Am J Transplant. 2008 Feb;8(2):419-25. doi: 10.1111/j.1600-6143.2007.02086.x.

14.

Extended criteria donors in liver transplantation: adapting donor quality and recipient.

Gastaca M.

Transplant Proc. 2009 Apr;41(3):975-9. doi: 10.1016/j.transproceed.2009.02.016.

PMID:
19376402
15.
16.

Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients.

Yosry A, Abdel-Rahman M, Esmat G, El-Serafy M, Omar A, Doss W, Zayed N, Said M, Ismail T, Hosny A, Marawan E, El-Malt O, Kamel RR, Hatata Y, El-Taweel A, Ghali A, Sabri H, Kamel S, El-Gabaly H.

Exp Clin Transplant. 2009 Sep;7(3):157-63.

17.

A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.

Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L, McGilvray ID, Therapondos G, Adcock LE, Ghanekar A, Levy GA, Renner EL, Grant DR.

Liver Transpl. 2009 Dec;15(12):1776-82. doi: 10.1002/lt.21955.

18.

Outcomes of kidney transplantation from older living donors to older recipients.

Gill J, Bunnapradist S, Danovitch GM, Gjertson D, Gill JS, Cecka M.

Am J Kidney Dis. 2008 Sep;52(3):541-52. doi: 10.1053/j.ajkd.2008.05.017.

PMID:
18653267
19.

Whole liver versus split liver versus living donor in the adult recipient: an analysis of outcomes by graft type.

Humar A, Beissel J, Crotteau S, Kandaswamy R, Lake J, Payne W.

Transplantation. 2008 May 27;85(10):1420-4. doi: 10.1097/TP.0b013e31816de1a3.

PMID:
18497681
20.

Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.

Schwartz JJ, Pappas L, Thiesset HF, Vargas G, Sorensen JB, Kim RD, Hutson WR, Boucher K, Box T.

Liver Transpl. 2012 Apr;18(4):423-33. doi: 10.1002/lt.23385.

Items per page

Supplemental Content

Support Center